![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 1531-8257|33|2|342-342
ISSN: 0885-3185
Source: MOVEMENT DISORDERS, Vol.33, Iss.2, 2018-02, pp. : 342-342
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The importance of cholesterol in Parkinson's disease
MOVEMENT DISORDERS, Vol. 33, Iss. 2, 2018-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lipid metabolism in Alzheimer’s and Parkinson’s disease
Future Lipidology, Vol. 1, Iss. 4, 2006-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study
MOVEMENT DISORDERS, Vol. 30, Iss. 4, 2015-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Plasma fasting cholesterol profiles and age at onset in Parkinson's disease
MOVEMENT DISORDERS, Vol. 30, Iss. 14, 2015-12 ,pp. :